SignificanceCystoid macular edema (CME) is a common complication of retinitis pigmentosa (RP). However, CME in RP with central retinal vein occlusion (CRVO) is rare. Prompt administration of anti-vascular endothelial growth factor (anti-VEGF) medication can achieve a satisfactory prognosis. PurposeThis report describes a case of using anti-VEGF medication to treat CME secondary to RP with impending or mild CRVO. Case ReportA 26-year-old female presented for blurred vision in both eyes. Best-corrected visual acuity (BCVA) was 20/50 in the right eye and finger-counting in the left eye. According to ophthalmic examinations, CME secondary to RP in the right eye and CME secondary to RP with impending or mild CRVO in her left eye can be diagnosed. Central macular thickness (CMT) was 554 mu m in the right eye and 831 mu m in the left eye. Only the left eye was treated with a single intravitreal injection of anti-VEGF medication. One month later, BCVA increased to 20/200 and CMT decreased to 162 mu m in the left eye. Interestingly, BCVA in the right eye also had an improvement (20/40) and intraretinal fluid decreased significantly. However, 3 months after injection, these improvements of both eyes were not maintained. ConclusionThis is the second case of RP with CRVO. Intravitreal injection of anti-VEGF medication for addressing CME secondary to RP with CRVO is an effective treatment, but it needs to be reinjected.
[1]Shanghai Univ Tradit Chinese Med, Dept Ophthalmol, Longhua Hosp, Shanghai, Peoples R China.
[2]Shanghai Xinshijie Zhongxing Eye Hosp, Dept Ophthalmol, Shanghai, Peoples R China.
[3]Fudan Univ, Dept Ophthalmol, Zhongshan Hosp, Shanghai, Peoples R China.
[4]Fudan Univ, Ctr Evidence Based Med, Shanghai, Peoples R China.
(8.0+极速模式)